Magnesium sulphate within multimodal analgesia, pre-emptive, or preventive analgesia | ||
| Ain-Shams Journal of Anesthesiology | ||
| Volume 14, Issue 1, January 2022 PDF (1.62 M) | ||
| DOI: 10.1186/s42077-021-00210-1 | ||
| Authors | ||
| Walid Y. Kamel* ; Aktham Adel Shoukry | ||
| Abstract | ||
| Background Magnesium (Mg) is a non-competitive -methyl -aspartate receptor antagonist with antinociceptive effects. Multimodal therapy is the optimal strategy for perioperative pain control to minimize the need for opioids. Inflammation caused by tissue trauma or direct nerve injury is responsible for the perioperative pain. The concept of “pre-emptive” analgesia, analgesic strategies administered prior to the stimulus, can modify the peripheral and central nervous system processing of noxious stimuli, thereby reducing central sensitization, hyperalgesia, and allodynia remains controversial. A more encompassing approach to the reduction of postoperative pain is the concept of “preventive” analgesia. The purpose of the study is to detect the proper use of MgSO4 as an analgesic being a non-competitive -methyl -aspartate (NMDA). Results There is no statistically significant difference in the haemodynamic parameters, intraoperative (33% vs 20%) and postoperative requirement for analgesics 6.6% vs 10% among groups I and II, respectively. There is no significant difference in the numerical analogue scale, where 16 vs 17 patients with no pain, 12 vs 10 with mild pain, and 2 vs 3 with moderate pain in groups I and II, respectively. Conclusion The use of MgSO4 in a bolus with or without infusion is comparable in the control of intraoperative and postoperative pain. | ||
| Keywords | ||
| MgSO4; Analgesia; preventive; Pre-emptive | ||
|
Statistics Article View: 107 PDF Download: 97 |
||
